ACUVUE® Portfolio
Footnotes
* ‘Excellent Vision’ claim does not include ACUVUE® Soft Contact Lenses indicated for myopia management.
† Subjective Comfort Data has not been collected for the ACUVUE® drug-eluting [medication releasing] contact lenses.
^ All ACUVUE® Contact Lenses have Class 1 or Class 2 UV-blocking to help provide protection against transmission of harmful UV radiation to the cornea and into the eye. UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. UV transmission measured with -1.00 lens.
§ n≥449.
**n=378.
# Filtering of HEV light by contact lenses has not been demonstrated to confer any health benefit to the user, including but not limited to retinal protection, protection from cataract progression, reduced eye strain, improved contrast, improved acuity, reduced glare, improved low light vision, or improved circadian rhythm/sleep cycle. The Eye Care Professional should be consulted for more information.
± Versus publicly available information for standard daily use contact lenses as of June 2023.
¥ Designed to support the functions of the tear film.
‡ Based on in-vitro data, clinical studies have not been done directly linking differences in lysozyme profile with specific clinical benefits.
§§ ClinicalTrials.gov is a website maintained by the NIH. The 14 clinical studies evaluated subjective comfort as a primary or secondary endpoint for 1-DAY ACUVUE® MOIST Brand family (spherical, astigmatism, and multifocal) contact lenses vs. competitors’ products. Review conducted as of October 31, 2023.
†† ClinicalTrials.gov is a website maintained by the NIH. The 20 clinical studies evaluated objective and subjective vision as a primary or secondary endpoint for 1-DAY ACUVUE® MOIST Brand family (spherical, astigmatism, and multifocal) contact lenses vs. competitors’ products. Review conducted as of October 31, 2023.
¥¥ ClinicalTrials.gov is a website maintained by the NIH. The 22 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand 2-week family contact lenses vs. competitors’ products. Review conducted as of October 31, 2023.
1. JJV Data on File 2022: Master Brand Claims on Clinical Performance and Overall Material Properties for ACUVUE® Brand Soft Contact Lenses.
2. JJV Data on File 2020. ACUVUE® Brand - Eye-Inspired® Innovations.
3. JJV Data on File 2022. TearStable™ Technology Definition.
4. JJV Data on File 2022. Effect on Tear Film and Evaluation of Visual Artifacts of ACUVUE® OASYS MAX 1-Day Family with TearStable™ Technology.
5. JJV Data on File 2022. Material Properties: 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® TruEye®, ACUVUE® OASYS 1-Day with HydraLuxe® Technology and ACUVUE® OASYS MAX 1-Day with TearStable™ Technology Brand Contact Lenses and other daily disposable contact lens brands.
6. JJV Data on File, 2022. CSM Subjective Responses ACUVUE® OASYS MAX 1-Day Contact Lenses- Retrospective Meta-analysis.
7. JJV Data on File 2022. Subjective Stand-Alone Claims for ACUVUE® OASYS MAX 1-Day MULTIFOCAL Contact Lenses - Exploratory Meta-analysis.
8. JJV Data on File 2016. Single-masked, 2-visit, bilateral wear, single arm 1-week daily wear dispensing study of 162 US habitual toric soft contact lens wearers in both eyes, with a spherical distance refraction of -1.50D to -4.00D (inclusive), cylinder correction of 0.75D to 1.50D after vertex correction (inclusive), and refractive cylinder axis within 180±15 degrees or 90±15 degrees.
9. JJV Data on File 2015. 1-week dispensing evaluation, daily wear study, n=119 soft contact lens wearers in the United States.
10. JJV Data on File 2021. HydraLuxe® Technology Definition.
11. JJV Data on File 2016. Design Enhancements and Resultant Benefits of ACUVUE® OASYS Brand Contact Lenses 1-Day with HydraLuxe® Technology for ASTIGMATISM.
12. JJV Data on File 2018. Similarities between Mucin and Poly(N-Vinyl Pyrrolidone) (PVP).
13. JJV Data on File 2017. Optical Precision of ACUVUE® OASYS Brand 1-Day Contact Lenses with HydraLuxe® Technology.
14. JJV Data on File 2021. Dual Action Technology and “Cushion of Moisture” Description for 1-DAY ACUVUE® MOIST Brand Family of Contact Lenses.
15. Heynen M, Omali NB, Fadli Z, et al. Selectivity and localization of lysozyme uptake in contemporary hydrogel contact lens materials. J Biomater. Sci. Polym. Ed. 2017;28(13):1351-1364. doi: 10.1080/09205063.2017.1327751.
16. JJV Data on File 2020. ACUVUE® OASYS MULTIFOCAL Fit and Performance Claims.
17. Canavan K, Sulley A, Coles-Brennan C, et al. Multi-Center Clinical Evaluation of Lapsed Wearers Refitted with senofilcon A Contact Lenses. Optom Vis Sci 2014;91:e-abstract 145180.
18. JJV Data on File 2017. A 4-week randomized, masked, controlled, cross-over, dispensing daily wear study with ACUVUE® OASYS vs. ULTRA, n=127 subjects who spent greater than or equal to 8 hours per day using digital devices during the study period.
ACUVUE® Contact Lenses are indicated for vision correction. For detailed product description and safety information, please consult the Instructions for Use or visit our Johnson & Johnson website www.e-IFU.com © Johnson & Johnson Medical Ltd 2024. ACUVUE®, ACUVUE® OASYS MAX 1-Day, ACUVUE® OASYS, ACUVUE® OASYS 1-Day, 1-Day ACUVUE® MOIST, HydraLuxe®, LACREON®, HYDRACLEAR®, TearStable™ and OptiBlue™ are registered trademarks of Johnson & Johnson © Johnson & Johnson Medical Ltd. 2024.
